![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Testosterone recovery following ADT varies across patients, study …
Sep 26, 2024 · Findings from the pooled analysis were published in European Urology. 1 “Our findings give patients and doctors valuable insights into what to expect after ADT treatment, …
BPH is linked with erectile dysfunction in US men
Oct 19, 2024 · Discussing the background for the study, investigator Olivia Paulsen told Urology Times, “We know that [BPH] has an association with lower urinary tract symptoms, but its …
Urology Times | News & Insights for Urologists & Health …
Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.
Expert compares PSMA imaging agents, discusses PSMA vs …
Nov 12, 2021 · Now that there are 2 FDA-approved PSMA-PET imaging agents, urologists and other clinicians are asking about the differences between them, as well as how PSMA-PET …
Intravesical gemcitabine/docetaxel for NMIBC appears safe and …
Apr 7, 2023 · The current study is welcome news as it lends further support to the use of intravesical Gem/Doce as a safe and effective option that has the potential to become a new …
The potential role for IsoPSA in prostate cancer risk assessment
Jun 23, 2024 · In this interview, Jason M. Hafron, MD, discusses how IsoPSA, a blood test for the assessment of risk for high-grade prostate cancer, fits into the current diagnostic and …
Low-intensity shockwave therapy, plasma injections efficacious for ...
Oct 20, 2024 · Regenerative treatment including low-intensity shockwave therapy (LiWST) and platelet-rich plasma (PRP) injections, as well as a combination of both, may be efficacious for …
SBRT shows tolerability in high-risk and recurrent prostate cancer
Mar 26, 2024 · Data presented at the 2024 Radiosurgery Society (RSS) Meeting in Chicago, Illinois showed that treatment with stereotactic body radiation therapy (SBRT) using the …
Decipher prostate test receives high evidence rating in NCCN …
Feb 28, 2024 · The Decipher Prostate Genomic Classifier has received a Level 1B evidence rating, the highest rating among molecular tests, in the 2024 National Comprehensive Cancer …
How testosterone therapy use in men with prostate cancer has …
Jan 5, 2023 · MD, professor of urology and chief of andrology at Tulane University School of Medicine, in New Orleans, Louisiana. “About 20 years ago, when I gave a course at the …